Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Steve Leeder, PharmD, PhD (he/him/his)

Executive Director
Children's Mercy Kansas City

J. Steven Leeder, PharmD, PhD, is the Marion Merrell Dow/Missouri Endowed Chair in Pediatric Clinical Pharmacology and Director, Div of Clinical Pharmacology, Toxicology & Therapeutic Innovation at Children’s Mercy Kansas City (CMKC), Kansas City, Missouri. He also serves as Associate Chair of Research, Dept of Pediatrics and Deputy Director of the Children’s Research Inst at CMKC, and holds faculty appointments in the Schools of Medicine and Pharmacy at the Univ of Missouri Kansas City, the Dept of Pediatrics at the Univ of Kansas Medical Ctr Kansas City and the Dept of Pharmaceutical Chemistry, Univ of Kansas School of Pharmacy, Lawrence, Kansas. His research focuses on the application of pharmacogenetic and pharmacogenomic strategies to characterize the relative contributions of ontogeny, genetic variation and disease to observed variability in drug disposition and response in children. Clinical application of this research is embodied in the GOLDILOKs initiative at CMH: Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids.

Disclosure information not submitted.

Presentation(s):